Sequenom is the trusted source for genetic testing that guides reproductive health matters. The Company is dedicated to delivering the most advanced genetic testing solutions available to provide answers that assist parents and physicians in proactively addressing informed family planning.

Sequenom offers the broadest collection of carrier status, NIPT, and diagnostic test options—from assessing a baby’s whole genome to detecting specific conditions—so that parents and physicians can select the right test for each pregnancy.

TypeSubsidiary
Parent CompanyLaboratory Corporation of America Holdings
HQSan Diego, US
Founded1994
Websitesequenom.com
Sequenom was founded in 1994 and is headquartered in San Diego, US
Report incorrect company information

Viewing summary data as a guest

Sign up for free to see all data

Sequenom Office Locations

Sequenom has offices in San Diego, Philadelphia, Salt Lake City, Los Angeles and in 17 other locations
San Diego, US (HQ)
3595 John Hopkins Ct
Show all (21)
Report incorrect company information

Sequenom Financials and Metrics

Summary Metrics

Founding Date

1994

Total Funding

$1.5 m
In total, Sequenom had raised $1.5 m. Sequenom is a subsidiary of Laboratory Corporation of America Holdings

Sequenom Revenue

Embed Graph
Sequenom's revenue was reported to be $128.28 m in FY, 2015 which is a 15.4% decrease from the previous period.
Annual
USDFY, 2013FY, 2014FY, 2015

Revenue

162.4 m151.6 m128.3 m

Revenue growth, %

(7%)(15%)

Cost of goods sold

102.7 m83.5 m67 m

Gross profit

59.7 m68.1 m61.3 m
Quarterly
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016

Revenue

44 m46.3 m37.8 m32.8 m29.9 m27.6 m29.3 m

Cost of goods sold

27 m26.1 m19.3 m16.6 m15.1 m16.8 m13.8 m

Gross profit

16.9 m20.2 m18.5 m16.2 m14.8 m10.8 m15.5 m

Gross profit Margin, %

38%44%49%49%50%39%53%
Annual
USDFY, 2013FY, 2014FY, 2015

Cash

61.6 m63.3 m50.3 m

Accounts Receivable

10.2 m9.1 m6.4 m

Inventories

17 m6.5 m2.4 m

Current Assets

101.5 m121.7 m89 m
Quarterly
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016

Cash

38.8 m45.3 m76.6 m45.3 m60.1 m56.2 m49.7 m45.2 m60.7 m

Accounts Receivable

8.6 m10.2 m5.5 m6.6 m7.7 m5.8 m6.3 m7 m7.3 m

Inventories

20.2 m13 m5 m6 m4.8 m3.5 m4.6 m3 m4.3 m

Current Assets

117.8 m83.1 m96.2 m86.8 m108.6 m102.2 m96.6 m79 m75.4 m
Annual
USDFY, 2013FY, 2014FY, 2015

Net Income

(107.4 m)1 m(16.3 m)

Depreciation and Amortization

15.1 m12.2 m

Inventories

(6.2 m)5.1 m

Accounts Payable

(90 k)(5.7 m)
Quarterly
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q1, 2016Q2, 2016

Net Income

(28.1 m)(15.7 m)4.5 m(6.1 m)14.3 m(13.4 m)(19.8 m)

Depreciation and Amortization

2.2 m3.4 m

Inventories

(148 k)(1.4 m)

Accounts Payable

(1.1 m)(519 k)
Show all financial metrics
Report incorrect company information

Sequenom Online and Social Media Presence

Embed Graph
Report incorrect company information

Sequenom News and Updates

Global Laboratory-developed Testing Market 2017 Segmentation, Demand, Growth, Trend, Opportunity and Forecast to 2023

Global Laboratory-developed Testing market is estimated at $11.52 billion in 2016 and is expected to reach $18.92 billion by 2023 growing at a CAGR of 7.3% from 2016 to 2023 Posted via Industry Today. Follow us on Twitter @IndustryToday
Report incorrect company information

Sequenom Company Life and Culture

Report incorrect company information